P. Perros, P. Kendall-Taylor, Thyroid-associated ophthalmopathy: pathogenesis and clinical management. Baillieres Clin. Endocrinol. Metab. 9, 115e135 (1995)
W.M. Wiersinga, M.F. Prummel, C.B. Terwee, Effects of Graves’ophthalmopathy on quality of life. Endocrinol. Invest. 27, 259e264 (2004)
M. Bahmani-Kashkouli, F. Pakdel, A. Astaraki et al. Quality of life in patients with thyroid eye disease. J. Ophthalmic Vis. Res. 4, 164e168 (2009)
L. Bartalena, E. Piantanida, D. Gallo, A. Lai, M.L. Tanda, Epidemiology, natural history, risk factors, and prevention of graves’ orbitopathy. Front Endocrinol. (Lausanne) 11, 615993 (2020)
L. Bartalena, L. Baldeschi, K. Boboridis et al. The 2016 European Thyroid Association/European Group on Graves’ Orbitopathy guidelines for the management of Graves’ orbitopathy. Eur. Thyroid J. 5(1), 9–26 (2016)
A.K. Eckstein, A. Finkenrath, A. Heiligenhaus et al. Dry eye syndrome in thyroid-associated ophthalmo- pathy: lacrimal expression of TSH receptor suggests involvement of TSHR-specific autoantibodies. Acta Ophthalmol. Scand. 82, 291–297 (2004)
M.A. Harris, T. Realini, J.P. Hogg, J.A. Sivak-Callcott, CT dimensions of the lacrimal gland in Graves orbitopathy. Ophthal Plast. Reconstr. Surg. 28, 69–72 (2012)
C.M. Bingham, M.A. Harris, T. Realini, J. Nguyen, J.P. Hogg, J.A. Sivak Callcott, Calculated computed tomography volumes of lacrimal glands and comparison to clinical findings in patients with thyroid eye disease. Ophthal Plast. Reconstr. Surg. 30, 116–118 (2014)
C. Gagliardo, S. Radellini, R. Morreale Bubella et al. Lacrimal gland herniation in Graves ophthalmopathy: a simple and useful MRI biomarker of disease activity. Eur. Radiol. 30, 2138–2141 (2020)
D.D. Wu, H.Z. Zhu, S.B. Hong et al. Utility of multi-parametric quantitative magnetic resonance imaging of the lacrimal gland for diagnosing and staging Graves’ ophthalmopathy. Eur. J. Radiol. 141, 109815 (2021)
N. Sollmann, D. Weidlich, E. Klupp et al. T2 mapping of the distal sciatic nerve in healthy subjects and patients suffering from lumbar disc herniation with nerve compression. MAGMA 33(5), 713–724 (2020)
K. Hou, T. Ai, W.K. Hu, B. Luo, Y.P. Wu, R. Liu, Three dimensional orbital magnetic resonance T2-mapping in the evaluation of patients with Graves’ ophthalmopathy. J. Huazhong Univ. Sci. Technol. Med. Sci. 37(6), 9 3 8–99 (2017)
G.B. Bartley, C.A. Gorman, Diagnostic criteria for Graves’ ophthalmopathy. Am. J. Ophthalmol. 119(6), 792–795 (1995)
M.P. Mourits, M.F. Prummel, W.M. Wiersinga, L. Koornneef, Clinical activity score as a guide in the management of patients with Graves’ ophthalmopathy. Clin. Endocrinol. 47(1), 9–14 (1997)
M. Salvi, D. Dazzi, I. Pellistri, F. Neri, J.R. Wall, Classification and prediction of the progression of thyroid-associated ophthalmopathy by an artificial neural network. Ophthalmology 109, 1703e1708 (2002)
M.A. Harris, T. Realini, J.P. Hogg, J.A. Sivak Callcott, CT dimensions of the lacrimal gland in Graves orbitopathy. Ophthal. Plast. Reconstr. Surg. 28(1), 69–72 (2012)
S. Inoue, M. Kawashima, R. Arita, A. Kozaki, K. Tsubota, Investigation of meibomian gland function and dry eye disease in patients with Graves’ ophthalmopathy. J. Clin. Med. 9(9), 2814 (2020).
J.H. Selter, A.I. Gire, S. Sikder, The relationship between Graves’ ophthalmopathy and dry eye syndrome. Clin. Ophthalmol. 9, 57–62 (2015)
L.H. Jiang, R.L. Wei, Analysis of Graves’ ophthalmopathy patients’ tear protein spectrum. Chin. Med. 126(23), 4493–4498 (2013)
C. Aass, I. Norheim, E.F. Eriksen, E.C. Bornick, P.M. Thorsby, M. Pepaj, Comparative proteomic analysis of tear fluid in Graves’ disease with and without orbitopathy. Clin. Endocrinol. 85(5), 805–812 (2016)
D. Huang, Q. Luo, H. Yang, Y. Mao, Changes of lacrimal gland and tear inflammatory cytokines in thyroid-associated ophthalmopathy. Invest. Ophthalmol. Vis. Sci. 55(8), 4935–4943 (2014)
J.S. Byun, N.J. Moon, J.K. Lee, Quantitative analysis of orbital soft tissues on computed tomography to assess the activity of thyroid-associated orbitopathy. Graefes Arch. Clin. Exp. Ophthalmol. 255, 413–420 (2017)
H.D. Huh, J.H. Kim, S.J. Kim, J.M. Yoo, S.W. Seo, The change of lacrimal gland volume in Korean patients with thyroid-associated ophthalmopathy. Korean J. Ophthalmol. 30, 319–325 (2016)
H. Hu, X.Q. Xu, F.Y. Wu et al. Diagnosis and stage of Graves’ ophthalmopathy: Efficacy of quantitative measurements of the lacrimal gland based on 3-T magnetic resonance imaging. Exp. Ther. Med. 12, 725–729 (2016)
L. Chen, H. Hu, W. Chen et al. Usefulness of readout-segmented EPI-based diffusion tensor imaging of lacrimal gland for detection and disease staging in thyroid-associated ophthalmopathy. BMC Ophthalmol. 21, 281 (2021)
R.X. Zhao, T.T. Shi, S. Luo, Y.F. Liu, Z. Xin, J.K. Yang, The value of SPECT/CT imaging of lacrimal glands as a means of assessing the activity of Graves’ orbitopathy. Endocr. Connect 11, e210590 (2022)
S.H. Lee, Y.H. Lee, H.T. Song, J.S. Suh, Quantitative T2 mapping of knee cartilage: comparison between the synthetic MR imaging and the CPMG sequence. Magn. Reson Med Sci. 17, 344–349 (2018)
J. Le, Q. Peng, K. Sperling, Biochemical magnetic resonance imaging of knee articular cartilage: T1rho and T2 mapping as cartilage degeneration biomarkers. Ann. NY Acad. Sci. 1383, 34–42 (2016)
P.K. Kim, Y.J. Hong, D.J. Im et al. Myocardial T1 and T2 mapping: techniques and clinical applications. Korean J. Radio. 18, 113–131 (2017)
X.T. Liu, Y. Su, M.D. Jiang et al. Application of magnetic resonance imaging in the evaluation of disease activity in graves’ ophthalmopathy. Endocr. Pr. 27, 198–205 (2021)
Q. Lei, Q. Wan, L.S. Liu et al. Values of apparent diffusion coefficient and lesion-to-spinal cord signal intensity in diagnosing solitary pulmonary lesions: turbo spin-echo versus echo-planar imaging diffusion-weighted imaging. Biomed. Res. Int. 2021, 3345953 (2021)
S.P. Sourbron, D.L. Buckley, On the scope and interpretation of the Tofts models for DCE-MRI. Magn. Reson. Med. 66, 735–45. (2011)
M.L. Tanda, E. Piantanida, L. Liparulo et al. Prevalence and natural history of Graves’ orbitopathy in a large series of patients with newly diagnosed Graves’ hyperthyroidism seen at a single center. J. Clin. Endocrinol. Metab. 98, 1443–1449 (2013)
留言 (0)